{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:06:50Z","timestamp":1793995610610,"version":"4.8.0"},"publisher-location":"New York, NY","reference-count":178,"publisher":"Springer US","isbn-type":[{"value":"9781071611104","type":"print"},{"value":"9781071611111","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1111-1_1","type":"book-chapter","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T14:07:21Z","timestamp":1612879641000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Overview of Human Cytomegalovirus Pathogenesis"],"prefix":"10.1007","author":[{"given":"Heather L.","family":"Fulkerson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej T.","family":"Nogalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Collins-McMillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Yurochko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"key":"1_CR1","first-page":"1960","volume-title":"Fields Virology","author":"ES Mocarsk Jr","year":"2013","unstructured":"Mocarsk ES Jr et al (2013) Cytomegaloviruses. In: Knipe DM, Howley PM (eds) Fields Virology. Lippincott Williams & Wilkins, Philadelphia, pp 1960\u20132014"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/978-3-540-77349-8_23","volume-title":"Human Cytomegaloviruses","author":"W Britt","year":"2008","unstructured":"Britt W (2008) Manifestations of human cytomegalovirus infection: Proposed mechanisms of acute and chronic disease. In: Stinksi MF, Shenk T (eds) Human Cytomegaloviruses. Springer-Verlag, Berlin, pp 417\u2013470"},{"issue":"2","key":"1_CR3","first-page":"251","volume":"21","author":"T Bravender","year":"2010","unstructured":"Bravender T (2010) Epstein-Barr virus, cytomegalovirus, and infectious mononucleosis. Adolesc Med State Art Rev 21(2):251\u2013264","journal-title":"Adolesc Med State Art Rev"},{"issue":"1","key":"1_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/clinids\/24.1.52","volume":"24","author":"M Eddleston","year":"1997","unstructured":"Eddleston M et al (1997) Severe cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 24(1):52\u201356","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jcv.2007.11.009","volume":"41","author":"C S\u00f6derberg-Naucl\u00e9r","year":"2008","unstructured":"S\u00f6derberg-Naucl\u00e9r C (2008) HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 41(3):218\u2013223","journal-title":"J Clin Virol"},{"issue":"1","key":"1_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1593\/neo.81178","volume":"11","author":"M Michaelis","year":"2009","unstructured":"Michaelis M, Doerr HW, Cinatl J (2009) The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 11(1):1\u20139","journal-title":"Neoplasia"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.virusres.2010.09.011","volume":"157","author":"P Caposio","year":"2011","unstructured":"Caposio P, Orloff SL, Streblow DN (2011) The role of cytomegalovirus in angiogenesis. Virus Res 157:204\u2013211","journal-title":"Virus Res"},{"key":"1_CR8","first-page":"397","volume":"325","author":"DN Streblow","year":"2008","unstructured":"Streblow DN et al (2008) Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol 325:397\u2013415","journal-title":"Curr Top Microbiol Immunol"},{"issue":"47","key":"1_CR9","doi-asserted-by":"publisher","first-page":"76735","DOI":"10.18632\/oncotarget.12523","volume":"7","author":"B Bai","year":"2016","unstructured":"Bai B et al (2016) Human cytomegalovirus infection and colorectal cancer risk: a meta-analysis. Oncotarget 7(47):76735\u201376742","journal-title":"Oncotarget"},{"issue":"1","key":"1_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12985-018-0937-3","volume":"15","author":"Y Du","year":"2018","unstructured":"Du Y, Zhang G, Liu Z (2018) Human cytomegalovirus infection and coronary heart disease: a systematic review. Virol J 15(1):31","journal-title":"Virol J"},{"issue":"12","key":"1_CR11","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1134\/S0006297918120027","volume":"83","author":"AM Lebedeva","year":"2018","unstructured":"Lebedeva AM et al (2018) Cytomegalovirus infection in cardiovascular diseases. Biochemistry (Mosc) 83(12):1437\u20131447","journal-title":"Biochemistry (Mosc)"},{"issue":"5","key":"1_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11908-017-0563-z","volume":"19","author":"JR McFaline-Figueroa","year":"2017","unstructured":"McFaline-Figueroa JR, Wen PY (2017) The viral connection to glioblastoma. Curr Infect Dis Rep 19(5):5","journal-title":"Curr Infect Dis Rep"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1128\/CMR.00062-12","volume":"26","author":"S Manicklal","year":"2013","unstructured":"Manicklal S et al (2013) The \"silent\" global burden of congenital cytomegalovirus. Clin Microbiol Rev 26:86\u2013102","journal-title":"Clin Microbiol Rev"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.spid.2004.09.011","volume":"16","author":"SA Ross","year":"2005","unstructured":"Ross SA, Boppana SB (2005) Congenital cytomegalovirus infection: outcome and diagnosis. Semin Pediatr Infect Dis 16:44\u201349","journal-title":"Semin Pediatr Infect Dis"},{"issue":"Suppl 4","key":"1_CR15","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1093\/cid\/cit629","volume":"57","author":"SB Boppana","year":"2013","unstructured":"Boppana SB, Ross SA, Fowler KB (2013) Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis 57(Suppl 4):S178\u2013S181","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/infdis\/121.6.608","volume":"121","author":"E Klemola","year":"1970","unstructured":"Klemola E et al (1970) Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J Infect Dis 121(6):608\u2013614","journal-title":"J Infect Dis"},{"issue":"2","key":"1_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.7326\/0003-4819-79-2-153","volume":"79","author":"MC Jordan","year":"1973","unstructured":"Jordan MC et al (1973) Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med 79(2):153\u2013160","journal-title":"Ann Intern Med"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.idcr.2017.10.008","volume":"10","author":"N Nolan","year":"2017","unstructured":"Nolan N et al (2017) Primary cytomegalovirus infection in immunocompetent adults in the United States\u2014A case series. IDCases 10:123\u2013126","journal-title":"IDCases"},{"issue":"12","key":"1_CR19","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1086\/379711","volume":"37","author":"TG Wreghitt","year":"2003","unstructured":"Wreghitt TG et al (2003) Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 37(12):1603\u20131606","journal-title":"Clin Infect Dis"},{"issue":"8554","key":"1_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0140-6736(87)90888-9","volume":"2","author":"E Adam","year":"1987","unstructured":"Adam E et al (1987) High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 2(8554):291\u2013293","journal-title":"Lancet"},{"issue":"1","key":"1_CR21","first-page":"23","volume":"136","author":"MG Hendrix","year":"1990","unstructured":"Hendrix MG et al (1990) High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 136(1):23\u201328","journal-title":"Am J Pathol"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0140-6736(83)92529-1","volume":"2","author":"JL Melnick","year":"1983","unstructured":"Melnick JL et al (1983) Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 2:644\u2013647","journal-title":"Lancet"},{"issue":"5","key":"1_CR23","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1161\/01.CIR.94.5.922","volume":"94","author":"FJ Nieto","year":"1996","unstructured":"Nieto FJ et al (1996) Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94(5):922\u2013927","journal-title":"Circulation"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/0014-4800(84)90050-9","volume":"40","author":"F Gyorkey","year":"1984","unstructured":"Gyorkey F et al (1984) Herpesviridae in the endothelial and smooth muscle cells of the proximal aorta in atherosclerotic patients. Exp Mol Pathol 40:328\u2013339","journal-title":"Exp Mol Pathol"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.5114\/amsad.2019.83304","volume":"4","author":"MO Beyaz","year":"2019","unstructured":"Beyaz MO et al (2019) Evaluation of the relationship between plaque formation leading to symptomatic carotid artery stenosis and cytomegalovirus by investigating the virus DNA. Arch Med Sci Atheroscler Dis 4:e19\u2013e24","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1056\/NEJM199608293350903","volume":"335","author":"YF Zhou","year":"1996","unstructured":"Zhou YF et al (1996) Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 335:624\u2013630","journal-title":"N Engl J Med"},{"issue":"5170","key":"1_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1126\/science.8023160","volume":"265","author":"E Speir","year":"1994","unstructured":"Speir E et al (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265(5170):391\u2013394","journal-title":"Science"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1161\/CIRCULATIONAHA.106.627570","volume":"115","author":"T Hussain","year":"2007","unstructured":"Hussain T et al (2007) Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children. Circulation 115:1798\u20131805","journal-title":"Circulation"},{"key":"1_CR29","first-page":"SS24","volume":"71","author":"C S\u00f6derberg-Naucl\u00e9r","year":"2001","unstructured":"S\u00f6derberg-Naucl\u00e9r C, Emery VC (2001) Viral infections and their impact on chronic renal allograft dysfunction. Transpantation 71:SS24\u2013SS30","journal-title":"Transpantation"},{"issue":"6","key":"1_CR30","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/S0735-1097(99)00410-6","volume":"34","author":"J Zhu","year":"1999","unstructured":"Zhu J et al (1999) Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. J Am Coll Cardiol 34(6):1738\u20131743","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/acel.12059","volume":"12","author":"GM Savva","year":"2013","unstructured":"Savva GM et al (2013) Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell 12(3):381\u2013387","journal-title":"Aging Cell"},{"issue":"2","key":"1_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/acel.12430","volume":"15","author":"I Spyridopoulos","year":"2016","unstructured":"Spyridopoulos I et al (2016) CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study. Aging Cell 15(2):389\u2013392","journal-title":"Aging Cell"},{"issue":"2","key":"1_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016103","volume":"6","author":"AM Simanek","year":"2011","unstructured":"Simanek AM et al (2011) Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 6(2):e16103","journal-title":"PLoS One"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1189\/jlb.0112040","volume":"92","author":"G Chan","year":"2012","unstructured":"Chan G et al (2012) Human cytomegalovirus induction of a unique signalsome during viral entry into monocytes mediates distinct functional changes: a strategy for viral dissemination. J Leukoc Biol 92:743\u2013752","journal-title":"J Leukoc Biol"},{"issue":"7","key":"1_CR35","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nri1882","volume":"6","author":"GK Hansson","year":"2006","unstructured":"Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6(7):508\u2013519","journal-title":"Nat Rev Immunol"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1073\/pnas.0800037105","volume":"105","author":"GL Bentz","year":"2008","unstructured":"Bentz GL, Yurochko AD (2008) HCMV infection of endothelial cells induces an angiogenic response through viral-binding to the epidermal growth factor receptor and the \u03b21 and \u03b23 integrins. Proc Natl Acad Sci U S A 105:5531\u20135536","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8 Suppl","key":"1_CR37","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","volume":"47","author":"E Falk","year":"2006","unstructured":"Falk E (2006) Pathogenesis of atherosclerosis. J Am Coll Cardiol 47(8 Suppl):C7\u2013C12","journal-title":"J Am Coll Cardiol"},{"issue":"6801","key":"1_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35025203","volume":"407","author":"AJ Lusis","year":"2000","unstructured":"Lusis AJ (2000) Atherosclerosis. Nature 407(6801):233\u2013241","journal-title":"Nature"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0092-8674(00)81539-1","volume":"99","author":"DN Streblow","year":"1999","unstructured":"Streblow DN et al (1999) The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99:511\u2013520","journal-title":"Cell"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1093\/jn\/131.10.2798S","volume":"131","author":"DN Streblow","year":"2001","unstructured":"Streblow DN, Orloff SL, Nelson JA (2001) Do pathogens accelerate atherosclerosis? J Nutr 131:2798\u20132804","journal-title":"J Nutr"},{"issue":"5","key":"1_CR41","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1159\/000447880","volume":"39","author":"L Li","year":"2016","unstructured":"Li L et al (2016) Lipid metabolism in vascular smooth muscle cells Infuenced by HCMV infection. Cell Physiol Biochem 39(5):1804\u20131812","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"1_CR42","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.bbrc.2018.04.106","volume":"504","author":"S Kohno","year":"2018","unstructured":"Kohno S et al (2018) Lipidomic insight into cardiovascular diseases. Biochem Biophys Res Commun 504(3):590\u2013595","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1_CR43","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.celrep.2016.05.070","volume":"16","author":"H Low","year":"2016","unstructured":"Low H et al (2016) Cytomegalovirus restructures lipid rafts via a US28\/CDC42-mediated pathway, enhancing cholesterol efflux from host cells. Cell Rep 16(1):186\u2013200","journal-title":"Cell Rep"},{"issue":"1","key":"1_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2013.09.019","volume":"63","author":"AS Jaipersad","year":"2014","unstructured":"Jaipersad AS et al (2014) The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol 63(1):1\u201311","journal-title":"J Am Coll Cardiol"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"7434376","DOI":"10.1155\/2019\/7434376","volume":"2019","author":"F Moroni","year":"2019","unstructured":"Moroni F et al (2019) The role of monocytes and macrophages in human atherosclerosis, plaque Neoangiogenesis, and Atherothrombosis. Mediat Inflamm 2019:7434376","journal-title":"Mediat Inflamm"},{"issue":"2","key":"1_CR46","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1161\/ATVBAHA.114.303565","volume":"35","author":"I Hilgendorf","year":"2015","unstructured":"Hilgendorf I, Swirski FK, Robbins CS (2015) Monocyte fate in atherosclerosis. Arterioscler Thromb Vasc Biol 35(2):272\u2013279","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"10714","DOI":"10.1128\/JVI.07129-11","volume":"92","author":"G Chan","year":"2012","unstructured":"Chan G, Nogalski MT, Yurochko AD (2012) Human cytomegalovirus stimulates monocyte-to-macrophage differentiation via the temporal regulation of caspace 3. J Virol 92:10714\u201310723","journal-title":"J Virol"},{"issue":"24","key":"1_CR48","doi-asserted-by":"publisher","first-page":"e00622","DOI":"10.1128\/JVI.00622-17","volume":"91","author":"D Collins-McMillen","year":"2017","unstructured":"Collins-McMillen D et al (2017) Human cytomegalovirus utilizes a nontraditional signal transducer and activator of transcription 1 activation cascade via signaling through epidermal growth factor receptor and integrins to efficiently promote the motility, differentiation, and polarization of infected monocytes. J Virol 91(24):e00622\u2013e00617","journal-title":"J Virol"},{"issue":"1","key":"1_CR49","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1182\/blood-2010-06-291245","volume":"117","author":"S Botto","year":"2011","unstructured":"Botto S et al (2011) IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin. Blood 117(1):352\u2013361","journal-title":"Blood"},{"issue":"3","key":"1_CR50","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1006\/bbrc.1999.0387","volume":"256","author":"YF Zhou","year":"1999","unstructured":"Zhou YF et al (1999) The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor. Biochem Biophys Res Commun 256(3):608\u2013613","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1_CR51","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.2353\/ajpath.2010.100307","volume":"177","author":"MV Khoretonenko","year":"2010","unstructured":"Khoretonenko MV et al (2010) Cytomegalovirus infection leads to microvascular dysfunction and exacerbates hypercholesterolemia-induced responses. Am J Pathol 177(4):2134\u20132144","journal-title":"Am J Pathol"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1600-6143.2004.00711.x","volume":"5","author":"DN Streblow","year":"2005","unstructured":"Streblow DN et al (2005) Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. Am J Transplant 5:436\u2013442","journal-title":"Am J Transplant"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-6143.2010.03365.x","volume":"11","author":"SL Orloff","year":"2011","unstructured":"Orloff SL et al (2011) Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV na\u00efve recipients. Am J Transplant 11:45\u201355","journal-title":"Am J Transplant"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1600-6143.2007.02062.x","volume":"8","author":"DN Streblow","year":"2008","unstructured":"Streblow DN et al (2008) The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants. Am J Transplant 8:277\u2013287","journal-title":"Am J Transplant"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"H183","DOI":"10.1152\/ajpheart.00461.2012","volume":"304","author":"RB Gombos","year":"2013","unstructured":"Gombos RB et al (2013) Vascular dysfunction in young, mid-aged and aged mice with latent cytomegalovirus infections. Am J Physiol Heart Circ Physiol 304:H183\u2013H194","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12265-012-9428-x","volume":"6","author":"YJ Tang-Feldman","year":"2013","unstructured":"Tang-Feldman YJ et al (2013) Murine cytomegalovirus (MCMV) infection upregulates P38 MAP kinase in aortas of Apo E KO mice: a molecular mechanism for MCMV-induced acceleration of atherosclerosis. J Cardiovasc Transl Res 6:54\u201364","journal-title":"J Cardiovasc Transl Res"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"6815","DOI":"10.1128\/JVI.00015-12","volume":"86","author":"B Bhattacharjee","year":"2012","unstructured":"Bhattacharjee B, Renzette N, Kowalik TF (2012) Genetic analysis of cytomegalovirus in malignant gliomas. J Virol 86:6815\u20136824","journal-title":"J Virol"},{"issue":"9345","key":"1_CR58","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/S0140-6736(02)11524-8","volume":"360","author":"L Harkins","year":"2002","unstructured":"Harkins L et al (2002) Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360(9345):1557\u20131563","journal-title":"Lancet"},{"issue":"3","key":"1_CR59","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/01.ju.0000080263.46164.97","volume":"170","author":"M Samanta","year":"2003","unstructured":"Samanta M et al (2003) High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170(3):998\u20131002","journal-title":"J Urol"},{"issue":"1","key":"1_CR60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2042-4280-1-8","volume":"1","author":"LE Harkins","year":"2010","unstructured":"Harkins LE et al (2010) Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Herpesviridae 1(1):8","journal-title":"Herpesviridae"},{"key":"1_CR61","first-page":"3347","volume":"62","author":"CS Cobbs","year":"2002","unstructured":"Cobbs CS et al (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347\u20133350","journal-title":"Cancer Res"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"12388","DOI":"10.1128\/JVI.00304-09","volume":"83","author":"ES Hwang","year":"2009","unstructured":"Hwang ES et al (2009) Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein. J Virol 83:12388\u201312398","journal-title":"J Virol"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1073\/pnas.94.7.3341","volume":"94","author":"Y Shen","year":"1997","unstructured":"Shen Y, Zhu H, Shenk T (1997) Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate \"hit-and-run\" oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci U S A 94:3341\u20133345","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"e1001342","DOI":"10.1371\/journal.ppat.1001342","volume":"7","author":"E Xiaofei","year":"2011","unstructured":"Xiaofei E et al (2011) An E2F1-mediated DNA damage response contributes to the replication of human cytomegalovirus. PLoS Pathog 7:e1001342","journal-title":"PLoS Pathog"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"11467","DOI":"10.1128\/JVI.79.17.11467-11475.2005","volume":"79","author":"JP Castillo","year":"2005","unstructured":"Castillo JP et al (2005) Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53\/p21-mediated growth arrest response. J Virol 79:11467\u201311475","journal-title":"J Virol"},{"key":"1_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1747-1028-4-1","volume":"4","author":"AJ Hume","year":"2009","unstructured":"Hume AJ, Kalejta RF (2009) Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div 4:1","journal-title":"Cell Div"},{"issue":"32","key":"1_CR67","doi-asserted-by":"publisher","first-page":"19666","DOI":"10.1074\/jbc.M115.660043","volume":"290","author":"S Iwahori","year":"2015","unstructured":"Iwahori S et al (2015) Molecular determinants for the inactivation of the retinoblastoma tumor suppressor by the viral cyclin-dependent kinase UL97. J Biol Chem 290(32):19666\u201319680","journal-title":"J Biol Chem"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.virol.2017.09.009","volume":"512","author":"S Iwahori","year":"2017","unstructured":"Iwahori S, Kalejta RF (2017) Phosphorylation of transcriptional regulators in the retinoblastoma protein pathway by UL97, the viral cyclin-dependent kinase encoded by human cytomegalovirus. Virology 512:95\u2013103","journal-title":"Virology"},{"issue":"16","key":"1_CR69","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1074\/jbc.M116.773150","volume":"292","author":"S Iwahori","year":"2017","unstructured":"Iwahori S et al (2017) Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins. J Biol Chem 292(16):6583\u20136599","journal-title":"J Biol Chem"},{"issue":"3","key":"1_CR70","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00430-015-0396-z","volume":"204","author":"DH Spector","year":"2015","unstructured":"Spector DH (2015) Human cytomegalovirus riding the cell cycle. Med Microbiol Immunol 204(3):409\u2013419","journal-title":"Med Microbiol Immunol"},{"issue":"15","key":"1_CR71","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.1074\/jbc.RA118.007049","volume":"294","author":"M Steingruber","year":"2019","unstructured":"Steingruber M et al (2019) Cyclins B1, T1, and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97. J Biol Chem 294(15):6188\u20136203","journal-title":"J Biol Chem"},{"issue":"35","key":"1_CR72","doi-asserted-by":"publisher","first-page":"13068","DOI":"10.1073\/pnas.0604433103","volume":"103","author":"D Maussang","year":"2006","unstructured":"Maussang D et al (2006) Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci U S A 103(35):13068\u201313073","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR73","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ebiom.2018.03.015","volume":"30","author":"A Kumar","year":"2018","unstructured":"Kumar A et al (2018) The human cytomegalovirus strain DB activates oncogenic pathways in mammary epithelial cells. EBioMedicine 30:167\u2013183","journal-title":"EBioMedicine"},{"issue":"1","key":"1_CR74","doi-asserted-by":"publisher","first-page":"12574","DOI":"10.1038\/s41598-018-30109-1","volume":"8","author":"FA Moussawi","year":"2018","unstructured":"Moussawi FA et al (2018) The transcriptome of human mammary epithelial cells infected with the HCMV-DB strain displays oncogenic traits. Sci Rep 8(1):12574","journal-title":"Sci Rep"},{"issue":"2","key":"1_CR75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.virusres.2010.10.026","volume":"157","author":"L Soroceanu","year":"2011","unstructured":"Soroceanu L, Cobbs CS (2011) Is HCMV a tumor promoter? Virus Res 157(2):193\u2013203","journal-title":"Virus Res"},{"issue":"4","key":"1_CR76","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000150527","volume":"39","author":"J Cinatl Jr","year":"1996","unstructured":"Cinatl J Jr et al (1996) Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology 39(4):259\u2013269","journal-title":"Intervirology"},{"key":"1_CR77","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jocn.2009.10.040","volume":"17","author":"K Barami","year":"2010","unstructured":"Barami K (2010) Oncomodulatory mechanisms of human cytomegalovirus in gliomas. J Clin Neurosci 17:819\u2013823","journal-title":"J Clin Neurosci"},{"key":"1_CR78","first-page":"739","volume":"1","author":"C S\u00f6derberg-Naucl\u00e9r","year":"2012","unstructured":"S\u00f6derberg-Naucl\u00e9r C, Johnsen JI (2012) Cytomegalovirus infection in brain tumors: a potential new target for therapy? Onco Targets Ther 1:739\u2013740","journal-title":"Onco Targets Ther"},{"issue":"4","key":"1_CR79","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/cancers11040447","volume":"11","author":"Z Yang","year":"2019","unstructured":"Yang Z et al (2019) Latent cytomegalovirus infection in female mice increases breast cancer metastasis. Cancers (Basel) 11(4):447","journal-title":"Cancers (Basel)"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1172\/JCI123375","volume":"130","author":"H Krenzlin","year":"2019","unstructured":"Krenzlin H et al (2019) Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis. J Clin Invest 130:1671\u20131683","journal-title":"J Clin Invest"},{"issue":"30","key":"1_CR81","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1038\/s41388-018-0255-7","volume":"37","author":"R Heukers","year":"2018","unstructured":"Heukers R et al (2018) The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth. Oncogene 37(30):4110\u20134121","journal-title":"Oncogene"},{"issue":"1","key":"1_CR82","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1215\/15228517-2007-035","volume":"10","author":"DA Mitchell","year":"2008","unstructured":"Mitchell DA et al (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-Oncology 10(1):10\u201318","journal-title":"Neuro-Oncology"},{"issue":"1","key":"1_CR83","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00401-008-0359-1","volume":"116","author":"ME Scheurer","year":"2008","unstructured":"Scheurer ME et al (2008) Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 116(1):79\u201386","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1_CR84","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/infdis\/168.2.449","volume":"168","author":"CY Shen","year":"1993","unstructured":"Shen CY et al (1993) High rate of concurrent genital infections with human cytomegalovirus and human papillomaviruses in cervical cancer patients. J Infect Dis 168(2):449\u2013452","journal-title":"J Infect Dis"},{"key":"1_CR85","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2042-4280-3-3","volume":"3","author":"A Rahbar","year":"2012","unstructured":"Rahbar A et al (2012) Low levels of human cytomegalovirus infection in glioblastoma multiforme associates with patient survival; -a case-control study. Herpesviridae 3:3","journal-title":"Herpesviridae"},{"issue":"8","key":"1_CR86","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/v10080408","volume":"10","author":"G Herbein","year":"2018","unstructured":"Herbein G (2018) The human cytomegalovirus, from oncomodulation to oncogenesis. Viruses 10(8):408","journal-title":"Viruses"},{"key":"1_CR87","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1128\/JVI.00502-08","volume":"82","author":"J Dumortier","year":"2008","unstructured":"Dumortier J et al (2008) Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing. J Virol 82:6524\u20136535","journal-title":"J Virol"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/rmv.368","volume":"13","author":"EA Fortunato","year":"2003","unstructured":"Fortunato EA, Spector DH (2003) Viral induction of site-specific chromosome damage. Rev Med Virol 13:21\u201337","journal-title":"Rev Med Virol"},{"issue":"3","key":"1_CR89","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1053\/j.semperi.2018.02.002","volume":"42","author":"KB Fowler","year":"2018","unstructured":"Fowler KB, Boppana SB (2018) Congenital cytomegalovirus infection. Semin Perinatol 42(3):149\u2013154","journal-title":"Semin Perinatol"},{"issue":"8","key":"1_CR90","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/v10080405","volume":"10","author":"WJ Britt","year":"2018","unstructured":"Britt WJ (2018) Maternal immunity and the natural history of congenital human cytomegalovirus infection. Viruses 10(8):405","journal-title":"Viruses"},{"issue":"12","key":"1_CR91","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/00006454-200512000-00016","volume":"24","author":"SP Adler","year":"2005","unstructured":"Adler SP (2005) Congenital cytomegalovirus screening. Pediatr Infect Dis J 24(12):1105\u20131106","journal-title":"Pediatr Infect Dis J"},{"key":"1_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/942937","volume":"2011","author":"SP Adler","year":"2011","unstructured":"Adler SP (2011) Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol 2011:1\u20139","journal-title":"Infect Dis Obstet Gynecol"},{"key":"1_CR93","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/GCO.0b013e328342f1f6","volume":"23","author":"G Nigro","year":"2011","unstructured":"Nigro G, Adler SP (2011) Cytomegalovirus infections during pregnancy. Curr Opin Obstet Gynecol 23:123\u2013128","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"163.e1","DOI":"10.1016\/j.ajog.2008.08.037","volume":"200","author":"BC Marshall","year":"2009","unstructured":"Marshall BC, Adler SP (2009) The frequency of pregnancy and exposure to cytomegalovirus infections among women with a young child in day care. Am J Obstet Gynecol 200:163.e1\u2013163.e5","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"1_CR95","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/infdis\/jiy321","volume":"218","author":"MM Mussi-Pinhata","year":"2018","unstructured":"Mussi-Pinhata MM et al (2018) Seroconversion for cytomegalovirus infection during pregnancy and fetal infection in a highly seropositive population: \"the BraCHS study\". J Infect Dis 218(8):1200\u20131204","journal-title":"J Infect Dis"},{"issue":"2","key":"1_CR96","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2174\/1568005310101020179","volume":"1","author":"Z Vancikova","year":"2001","unstructured":"Vancikova Z, Dvorak P (2001) Cytomegalovirus infection in immunocompetent and immunocompromised individuals\u2014a review. Curr Drug Targets Immune Endocr Metabol Disord 1(2):179\u2013187","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"1_CR97","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1086\/600882","volume":"49","author":"MM Mussi-Pinhata","year":"2009","unstructured":"Mussi-Pinhata MM et al (2009) Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis 49:522\u2013528","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1_CR98","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ajo.12408","volume":"56","author":"ZW Naing","year":"2016","unstructured":"Naing ZW et al (2016) Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention. Aust N Z J Obstet Gynaecol 56(1):9\u201318","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"1_CR99","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jpeds.2013.12.007","volume":"164","author":"AM Dreher","year":"2014","unstructured":"Dreher AM et al (2014) Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr 164(4):855\u2013859","journal-title":"J Pediatr"},{"issue":"2","key":"1_CR100","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00006454-199202000-00007","volume":"11","author":"SB Boppana","year":"1992","unstructured":"Boppana SB et al (1992) Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11(2):93\u201399","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"1_CR101","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJM199203053261003","volume":"326","author":"KB Fowler","year":"1992","unstructured":"Fowler KB et al (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326(10):663\u2013667","journal-title":"N Engl J Med"},{"key":"1_CR102","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/jac\/dkp083","volume":"63","author":"L Nassetta","year":"2009","unstructured":"Nassetta L, Kimberlin D, Whitley R (2009) Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother 63:862\u2013867","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1_CR103","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/088307389000500212","volume":"5","author":"JF Bale Jr","year":"1990","unstructured":"Bale JF Jr, Blackman JA, Sato Y (1990) Outcome in children with symptomatic congenital cytomegalovirus infection. J Child Neurol 5(2):131\u2013136","journal-title":"J Child Neurol"},{"issue":"12","key":"1_CR104","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/archpedi.1990.02150360091031","volume":"144","author":"WD Williamson","year":"1990","unstructured":"Williamson WD et al (1990) Asymptomatic congenital cytomegalovirus infection. Audiologic, neuroradiologic, and neurodevelopmental abnormalities during the first year. Am J Dis Child 144(12):1365\u20131368","journal-title":"Am J Dis Child"},{"issue":"10","key":"1_CR105","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/archpedi.1982.03970460026006","volume":"136","author":"S Saigal","year":"1982","unstructured":"Saigal S et al (1982) The outcome in children with congenital cytomegalovirus infection. A longitudinal follow-up study. Am J Dis Child 136(10):896\u2013901","journal-title":"Am J Dis Child"},{"issue":"7","key":"1_CR106","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/cid\/ciz413","volume":"70","author":"AY Yamamoto","year":"2019","unstructured":"Yamamoto AY et al (2019) Contribution of congenital cytomegalovirus (cCMV) to permanent hearing loss in a highly seropositive population: \"the BraCHS study\". Clin Infect Dis 70(7):1379\u20131384","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1_CR107","doi-asserted-by":"publisher","first-page":"e20172526","DOI":"10.1542\/peds.2017-2526","volume":"140","author":"SB Boppana","year":"2017","unstructured":"Boppana SB, Fowler KB (2017) Insight into long-term neurodevelopmental outcomes in asymptomatic congenital cmv infection. Pediatrics 140(5):e20172526","journal-title":"Pediatrics"},{"issue":"14","key":"1_CR108","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1001\/jama.1986.03380140074025","volume":"256","author":"S Stagno","year":"1986","unstructured":"Stagno S et al (1986) Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 256(14):1904\u20131908","journal-title":"JAMA"},{"issue":"3","key":"1_CR109","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00430-015-0399-9","volume":"204","author":"W Britt","year":"2015","unstructured":"Britt W (2015) Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy. Med Microbiol Immunol 204(3):263\u2013271","journal-title":"Med Microbiol Immunol"},{"issue":"9","key":"1_CR110","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/cid\/cit018","volume":"56","author":"CL Townsend","year":"2013","unstructured":"Townsend CL et al (2013) Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. Clin Infect Dis 56(9):1232\u20131239","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1_CR111","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1651-2227.2011.02494.x","volume":"101","author":"S Ygberg","year":"2012","unstructured":"Ygberg S, Nilsson A (2012) The developing immune system\u2014from foetus to toddler. Acta Paediatr 101(2):120\u2013127","journal-title":"Acta Paediatr"},{"issue":"3","key":"1_CR112","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/00003081-198209000-00014","volume":"25","author":"S Stagno","year":"1982","unstructured":"Stagno S et al (1982) Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol 25(3):563\u2013576","journal-title":"Clin Obstet Gynecol"},{"key":"1_CR113","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/rmv.695","volume":"21","author":"MJ Cannon","year":"2011","unstructured":"Cannon MJ, Hyde TB, Schmid DS (2011) Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol 21:240\u2013255","journal-title":"Rev Med Virol"},{"issue":"1","key":"1_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM197307052890101","volume":"289","author":"DW Reynolds","year":"1973","unstructured":"Reynolds DW et al (1973) Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med 289(1):1\u20135","journal-title":"N Engl J Med"},{"issue":"1","key":"1_CR115","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clp.2016.11.012","volume":"44","author":"K Hamprecht","year":"2017","unstructured":"Hamprecht K, Goelz R (2017) Postnatal cytomegalovirus infection through human Milk in preterm infants: transmission, clinical presentation, and prevention. Clin Perinatol 44(1):121\u2013130","journal-title":"Clin Perinatol"},{"issue":"3","key":"1_CR116","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1542\/peds.72.3.295","volume":"72","author":"M Dworsky","year":"1983","unstructured":"Dworsky M et al (1983) Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 72(3):295\u2013299","journal-title":"Pediatrics"},{"issue":"9","key":"1_CR117","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/01.inf.0000137571.35541.55","volume":"23","author":"WT Jim","year":"2004","unstructured":"Jim WT et al (2004) Transmission of cytomegalovirus from mothers to preterm infants by breast milk. Pediatr Infect Dis J 23(9):848\u2013851","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1_CR118","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00006454-199801000-00012","volume":"17","author":"M Vochem","year":"1998","unstructured":"Vochem M et al (1998) Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J 17(1):53\u201358","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"1_CR119","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1620\/tjem.117.143","volume":"117","author":"S Chiba","year":"1975","unstructured":"Chiba S et al (1975) Primary cytomegalovirus infection and liver involvement in early infancy. Tohoku J Exp Med 117(2):143\u2013151","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"1_CR120","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1542\/peds.68.3.322","volume":"68","author":"S Stagno","year":"1981","unstructured":"Stagno S et al (1981) Infant pneumonitis associated with cytomegalovirus, chlamydia, pneumocystis, and Ureaplasma: a prospective study. Pediatrics 68(3):322\u2013329","journal-title":"Pediatrics"},{"issue":"5","key":"1_CR121","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0022-3476(84)80941-5","volume":"104","author":"ML Kumar","year":"1984","unstructured":"Kumar ML et al (1984) Postnatally acquired cytomegalovirus infections in infants of CMV-excreting mothers. J Pediatr 104(5):669\u2013673","journal-title":"J Pediatr"},{"issue":"5","key":"1_CR122","first-page":"482","volume":"133","author":"RA Ballard","year":"1979","unstructured":"Ballard RA et al (1979) Acquired cytomegalovirus infection in preterm infants. Am J Dis Child 133(5):482\u2013485","journal-title":"Am J Dis Child"},{"issue":"2","key":"1_CR123","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0022-3476(81)80662-2","volume":"98","author":"AS Yeager","year":"1981","unstructured":"Yeager AS et al (1981) Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 98(2):281\u2013287","journal-title":"J Pediatr"},{"issue":"9255","key":"1_CR124","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0140-6736(00)04043-5","volume":"357","author":"K Hamprecht","year":"2001","unstructured":"Hamprecht K et al (2001) Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 357(9255):513\u2013518","journal-title":"Lancet"},{"issue":"3","key":"1_CR125","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1537-2995.1992.32392213801.x","volume":"32","author":"L Eisenfeld","year":"1992","unstructured":"Eisenfeld L et al (1992) Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion 32(3):205\u2013209","journal-title":"Transfusion"},{"issue":"8649","key":"1_CR126","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S0140-6736(89)92330-1","volume":"1","author":"GL Gilbert","year":"1989","unstructured":"Gilbert GL et al (1989) Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1(8649):1228\u20131231","journal-title":"Lancet"},{"issue":"1","key":"1_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2011","volume":"29","author":"QY Zheng","year":"2019","unstructured":"Zheng QY et al (2019) Cytomegalovirus infection in day care centres: a systematic review and meta-analysis of prevalence of infection in children. Rev Med Virol 29(1):e2011","journal-title":"Rev Med Virol"},{"issue":"22","key":"1_CR128","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1056\/NEJM198605293142205","volume":"314","author":"SW Chou","year":"1986","unstructured":"Chou SW (1986) Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N Engl J Med 314(22):1418\u20131423","journal-title":"N Engl J Med"},{"issue":"6","key":"1_CR129","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/infdis\/150.6.952","volume":"150","author":"WL Drew","year":"1984","unstructured":"Drew WL et al (1984) Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by southern blot hybridization. J Infect Dis 150(6):952\u2013953","journal-title":"J Infect Dis"},{"issue":"8603","key":"1_CR130","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(88)90685-X","volume":"2","author":"JE Grundy","year":"1988","unstructured":"Grundy JE et al (1988) Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 2(8603):132\u2013135","journal-title":"Lancet"},{"issue":"10","key":"1_CR131","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1099\/jgv.0.000916","volume":"98","author":"V Vinuesa","year":"2017","unstructured":"Vinuesa V et al (2017) The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients. J Gen Virol 98(10):2530\u20132542","journal-title":"J Gen Virol"},{"issue":"12","key":"1_CR132","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1073\/pnas.1818130116","volume":"116","author":"J Cudini","year":"2019","unstructured":"Cudini J et al (2019) Human cytomegalovirus haplotype reconstruction reveals high diversity due to superinfection and evidence of within-host recombination. Proc Natl Acad Sci U S A 116(12):5693\u20135698","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"1_CR133","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1056\/NEJM198710223171703","volume":"317","author":"DR Snydman","year":"1987","unstructured":"Snydman DR et al (1987) Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med 317(17):1049\u20131054","journal-title":"N Engl J Med"},{"issue":"16","key":"1_CR134","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","volume":"333","author":"EA Walter","year":"1995","unstructured":"Walter EA et al (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333(16):1038\u20131044","journal-title":"N Engl J Med"},{"issue":"3","key":"1_CR135","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00430-015-0415-0","volume":"204","author":"JG Sissons","year":"2015","unstructured":"Sissons JG, Wills MR (2015) How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future. Med Microbiol Immunol 204(3):307\u2013316","journal-title":"Med Microbiol Immunol"},{"issue":"6","key":"1_CR136","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nri.2016.38","volume":"16","author":"P Klenerman","year":"2016","unstructured":"Klenerman P, Oxenius A (2016) T cell responses to cytomegalovirus. Nat Rev Immunol 16(6):367\u2013377","journal-title":"Nat Rev Immunol"},{"issue":"8376","key":"1_CR137","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0140-6736(84)90930-9","volume":"1","author":"SA Plotkin","year":"1984","unstructured":"Plotkin SA et al (1984) Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet 1(8376):528\u2013530","journal-title":"Lancet"},{"issue":"50","key":"1_CR138","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.1016\/j.vaccine.2018.02.089","volume":"37","author":"SA Plotkin","year":"2018","unstructured":"Plotkin SA, Boppana SB (2018) Vaccination against the human cytomegalovirus. Vaccine 37(50):7437\u20137442","journal-title":"Vaccine"},{"issue":"2","key":"1_CR139","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/cmi.2014.120","volume":"12","author":"AL McCormick","year":"2015","unstructured":"McCormick AL, Mocarski ES (2015) The immunological underpinnings of vaccinations to prevent cytomegalovirus disease. Cell Mol Immunol 12(2):170\u2013179","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"1_CR140","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1086\/516446","volume":"175","author":"A Erice","year":"1997","unstructured":"Erice A et al (1997) Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised. patients. J Infect Dis 175(5):1087\u20131092","journal-title":"J Infect Dis"},{"key":"1_CR141","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcv.2019.04.007","volume":"116","author":"P Griffiths","year":"2019","unstructured":"Griffiths P (2019) New vaccines and antiviral drugs for cytomegalovirus. J Clin Virol 116:58\u201361","journal-title":"J Clin Virol"},{"issue":"10","key":"1_CR142","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1097\/00007890-200011270-00012","volume":"70","author":"CM Legendre","year":"2000","unstructured":"Legendre CM et al (2000) Valaciclovir prophylaxis of cytomegalovirus infection and disease in renal transplantation: an economic evaluation. Transplantation 70(10):1463\u20131468","journal-title":"Transplantation"},{"issue":"3","key":"1_CR143","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2165\/00019053-200018030-00004","volume":"18","author":"JA Mauskopf","year":"2000","unstructured":"Mauskopf JA et al (2000) Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valaciclovir prophylaxis with current practice. PharmacoEconomics 18(3):239\u2013251","journal-title":"PharmacoEconomics"},{"issue":"5","key":"1_CR144","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12961","volume":"20","author":"BJ Webb","year":"2018","unstructured":"Webb BJ et al (2018) The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation. Transpl Infect Dis 20(5):e12961","journal-title":"Transpl Infect Dis"},{"key":"1_CR145","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2147\/IDR.S196282","volume":"12","author":"U Restelli","year":"2019","unstructured":"Restelli U et al (2019) Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy. Infect Drug Resist 12:1127\u20131138","journal-title":"Infect Drug Resist"},{"issue":"2","key":"1_CR146","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.idc.2019.02.008","volume":"33","author":"A Pande","year":"2019","unstructured":"Pande A, Dubberke ER (2019) Cytomegalovirus infections of the stem cell transplant recipient and hematologic malignancy patient. Infect Dis Clin N Am 33(2):485\u2013500","journal-title":"Infect Dis Clin N Am"},{"issue":"3","key":"1_CR147","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","volume":"45","author":"P Ramanan","year":"2013","unstructured":"Ramanan P, Razonable RR (2013) Cytomegalovirus infections in solid organ transplantation: a review. Infect Chemother 45(3):260\u2013271","journal-title":"Infect Chemother"},{"key":"1_CR148","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2165\/10898540-000000000-00000","volume":"70","author":"AJ Eid","year":"2010","unstructured":"Eid AJ, Razonable RR (2010) New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs 70:965\u2013981","journal-title":"Drugs"},{"issue":"6","key":"1_CR149","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/jcph.1363","volume":"59","author":"AC Hodowanec","year":"2019","unstructured":"Hodowanec AC et al (2019) Treatment and prevention of CMV disease in transplant recipients: current knowledge and future perspectives. J Clin Pharmacol 59(6):784\u2013798","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"1_CR150","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2165\/00003495-199855010-00005","volume":"55","author":"H Hebart","year":"1998","unstructured":"Hebart H et al (1998) Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects. Drugs 55(1):59\u201372","journal-title":"Drugs"},{"issue":"2","key":"1_CR151","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/sj.bmt.1700630","volume":"19","author":"HG Prentice","year":"1997","unstructured":"Prentice HG, Kho P (1997) Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant. Bone Marrow Transplant 19(2):135\u2013142","journal-title":"Bone Marrow Transplant"},{"key":"1_CR152","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1172\/JCI45449","volume":"121","author":"M Boeckh","year":"2011","unstructured":"Boeckh M, Geballe AP (2011) Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest 121:1673\u20131680","journal-title":"J Clin Invest"},{"key":"1_CR153","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","volume":"25","author":"P Ljungman","year":"2011","unstructured":"Ljungman P, Hakki M, Boeckh M (2011) Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematol Oncol Clin North Am 25:151\u2013169","journal-title":"Hematol Oncol Clin North Am"},{"key":"1_CR154","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/petr.12118","volume":"17","author":"S Kowalsky","year":"2013","unstructured":"Kowalsky S, Arnon R, Posada R (2013) Prevention of cytomegalovirus following solid organ transplantation: a literature review. Pediatr Transplant 17:499\u2013509","journal-title":"Pediatr Transplant"},{"key":"1_CR155","first-page":"59","volume":"100","author":"P Ljungman","year":"1996","unstructured":"Ljungman P (1996) Cytomegalovirus infections in transplant patients. Scand J Infect Dis Suppl 100:59\u201363","journal-title":"Scand J Infect Dis Suppl"},{"issue":"6","key":"1_CR156","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1034\/j.1600-6143.2003.00140.x","volume":"3","author":"E Akalin","year":"2003","unstructured":"Akalin E et al (2003) Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis. Am J Transplant 3(6):731\u2013735","journal-title":"Am J Transplant"},{"issue":"9","key":"1_CR157","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/01.TP.0000145989.22373.03","volume":"78","author":"AP Limaye","year":"2004","unstructured":"Limaye AP et al (2004) Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis. Transplantation 78(9):1390\u20131396","journal-title":"Transplantation"},{"issue":"11","key":"1_CR158","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1086\/324516","volume":"184","author":"RR Razonable","year":"2001","unstructured":"Razonable RR et al (2001) Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis 184(11):1461\u20131464","journal-title":"J Infect Dis"},{"issue":"2","key":"1_CR159","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","volume":"101","author":"M Boeckh","year":"2003","unstructured":"Boeckh M et al (2003) Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 101(2):407\u2013414","journal-title":"Blood"},{"issue":"6","key":"1_CR160","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1128\/jvi.64.6.2932-2940.1990","volume":"64","author":"PA Barry","year":"1990","unstructured":"Barry PA et al (1990) Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. J Virol 64(6):2932\u20132940","journal-title":"J Virol"},{"issue":"6259","key":"1_CR161","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/343659a0","volume":"343","author":"JA McKeating","year":"1990","unstructured":"McKeating JA, Griffiths PD, Weiss RA (1990) HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature 343(6259):659\u2013661","journal-title":"Nature"},{"key":"1_CR162","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jcv.2005.10.016","volume":"35","author":"PD Griffiths","year":"2006","unstructured":"Griffiths PD (2006) CMV as a cofactor enhancing progression of AIDS. J Clin Virol 35:489\u2013492","journal-title":"J Clin Virol"},{"issue":"10","key":"1_CR163","doi-asserted-by":"publisher","first-page":"7772","DOI":"10.1128\/JVI.72.10.7772-7784.1998","volume":"72","author":"MA Ostrowski","year":"1998","unstructured":"Ostrowski MA et al (1998) Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies. J Virol 72(10):7772\u20137784","journal-title":"J Virol"},{"issue":"6","key":"1_CR164","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","volume":"166","author":"JE Gallant","year":"1992","unstructured":"Gallant JE et al (1992) Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis 166(6):1223\u20131227","journal-title":"J Infect Dis"},{"issue":"2","key":"1_CR165","first-page":"113","volume":"66","author":"TW Cheung","year":"1999","unstructured":"Cheung TW, Teich SA (1999) Cytomegalovirus infection in patients with HIV infection. Mt Sinai J Med 66(2):113\u2013124","journal-title":"Mt Sinai J Med"},{"issue":"10","key":"1_CR166","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1097\/INF.0000000000001975","volume":"37","author":"K Adachi","year":"2018","unstructured":"Adachi K et al (2018) Congenital cytomegalovirus and HIV perinatal transmission. Pediatr Infect Dis J 37(10):1016\u20131021","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"1_CR167","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/00002030-199907090-00008","volume":"13","author":"J Deayton","year":"1999","unstructured":"Deayton J et al (1999) Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy. AIDS 13(10):1203\u20131206","journal-title":"AIDS"},{"issue":"3","key":"1_CR168","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1086\/314943","volume":"180","author":"CE O\u2019Sullivan","year":"1999","unstructured":"O\u2019Sullivan CE et al (1999) Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy. J Infect Dis 180(3):847\u2013849","journal-title":"J Infect Dis"},{"key":"1_CR169","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1086\/319854","volume":"183","author":"MA Jacobson","year":"2001","unstructured":"Jacobson MA et al (2001) Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy. J Infect Dis 183:1399\u20131404","journal-title":"J Infect Dis"},{"key":"1_CR170","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.1128\/JVI.73.8.7027-7030.1999","volume":"73","author":"SA Spector","year":"1999","unstructured":"Spector SA et al (1999) Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS. J Virol 73:7027\u20137030","journal-title":"J Virol"},{"key":"1_CR171","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/S0140-6736(04)16500-8","volume":"363","author":"JR Deayton","year":"2004","unstructured":"Deayton JR et al (2004) Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet 363:2116\u20132121","journal-title":"Lancet"},{"issue":"1","key":"1_CR172","doi-asserted-by":"publisher","first-page":"66","DOI":"10.20411\/pai.v4i1.255","volume":"4","author":"AC Hodowanec","year":"2019","unstructured":"Hodowanec AC et al (2019) Increased CMV IgG antibody titer is associated with non-AIDS events among virologically suppressed HIV-positive persons. Pathog Immun 4(1):66\u201378","journal-title":"Pathog Immun"},{"issue":"3","key":"1_CR173","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/v11030200","volume":"11","author":"S Zicari","year":"2019","unstructured":"Zicari S et al (2019) Immune Activation, Inflammation, and non-AIDS Co-morbidities in HIV-infected patients under long-term ART. Viruses 11(3):200","journal-title":"Viruses"},{"issue":"2","key":"1_CR174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006202","volume":"13","author":"E Maidji","year":"2017","unstructured":"Maidji E et al (2017) Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction. PLoS Pathog 13(2):e1006202","journal-title":"PLoS Pathog"},{"issue":"S1","key":"1_CR175","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1089\/aid.2017.0145","volume":"33","author":"A Christensen-Quick","year":"2017","unstructured":"Christensen-Quick A et al (2017) Cytomegalovirus and HIV persistence: pouring gas on the fire. AIDS Res Hum Retrovir 33(S1):S23\u2013S30","journal-title":"AIDS Res Hum Retrovir"},{"issue":"Suppl 2","key":"1_CR176","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1093\/infdis\/jiw217","volume":"214","author":"S Gianella","year":"2016","unstructured":"Gianella S, Letendre S (2016) Cytomegalovirus and HIV: a dangerous pas de Deux. J Infect Dis 214(Suppl 2):S67\u2013S74","journal-title":"J Infect Dis"},{"key":"1_CR177","first-page":"382","volume":"2","author":"JN Dock","year":"2011","unstructured":"Dock JN, Effros RB (2011) Role of CD8 T cell replicative senescence in human aging and in HIV-mediated immunosenescence. Aging Dis 2:382\u2013397","journal-title":"Aging Dis"},{"key":"1_CR178","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mad.2015.09.003","volume":"158","author":"RB Effros","year":"2016","unstructured":"Effros RB (2016) The silent war of CMV in aging and HIV infection. Mech Ageing Dev 158:46\u201352","journal-title":"Mech Ageing Dev"}],"container-title":["Methods in Molecular Biology","Human Cytomegaloviruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1111-1_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T22:04:59Z","timestamp":1674943499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1111-1_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9781071611104","9781071611111"],"references-count":178,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1111-1_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"9 February 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}